Literature DB >> 9578138

Ascorbic acid stimulates DOPA synthesis and tyrosine hydroxylase gene expression in the human neuroblastoma cell line SK-N-SH.

G Seitz1, S Gebhardt, J F Beck, W Böhm, H N Lode, D Niethammer, G Bruchelt.   

Abstract

Ascorbic acid is well known to induce noradrenaline synthesis in sympathetic nervous cells. In a series of experiments we found that incubation of the neuroblastoma cell line SK-N-SH with ascorbic acid (100-500 microM) for 2 h results in a significantly enhanced synthesis of 3,4-dihydroxyphenylalanine (DOPA) and dopamine. Additionally, cDNA-polymerase chain reaction (cDNA-PCR) analysis of relative mRNA levels corresponding to the enzymes involved in catecholamine synthesis revealed a 3-fold increase of tyrosine hydroxylase gene expression after 5 days of incubation with ascorbic acid (200 microM), whereas expression of dopamine-beta-hydroxylase was found to be unaltered. In summary the data give evidence that ascorbic acid leads to enhanced DOPA production in SK-N-SH cells by two different mechanisms: at the metabolic level after short-term incubation and by increasing the tyrosine hydroxylase gene expression after long-term incubation. Based on these data we suppose that enhancement of DOPA synthesis by ascorbic acid may be useful in the treatment of early Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9578138     DOI: 10.1016/s0304-3940(98)00129-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  The hallucinogen 2,5-dimethoxy-4-iodoamphetamine hydrochloride activates neurotrophin receptors in a neuronal cell line and promotes neurites extension.

Authors:  Zoya Marinova; Susanne Walitza; Edna Grünblatt
Journal:  J Neural Transm (Vienna)       Date:  2017-03-18       Impact factor: 3.575

2.  Ascorbic acid efficiently enhances neuronal synthesis of norepinephrine from dopamine.

Authors:  James M May; Zhi-Chao Qu; Rafal Nazarewicz; Sergey Dikalov
Journal:  Brain Res Bull       Date:  2012-09-26       Impact factor: 4.077

3.  Regulation of embryonic neurotransmitter and tyrosine hydroxylase protein levels by ascorbic acid.

Authors:  M Elizabeth Meredith; James M May
Journal:  Brain Res       Date:  2013-10-01       Impact factor: 3.252

4.  The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: functional interrelationships in health and disease: a review-discussion.

Authors:  J Smythies
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

5.  Mechanisms of ascorbic acid stimulation of norepinephrine synthesis in neuronal cells.

Authors:  James M May; Zhi-chao Qu; M Elizabeth Meredith
Journal:  Biochem Biophys Res Commun       Date:  2012-08-19       Impact factor: 3.575

6.  Behavioral and monoamine changes following severe vitamin C deficiency.

Authors:  Margaret S Ward; Jonathan Lamb; James M May; Fiona E Harrison
Journal:  J Neurochem       Date:  2012-11-30       Impact factor: 5.372

7.  Effect of ascorbic acid deficiency on catecholamine synthesis in adrenal glands of SMP30/GNL knockout mice.

Authors:  Akiko Amano; Makoto Tsunoda; Toshiro Aigaki; Naoki Maruyama; Akihito Ishigami
Journal:  Eur J Nutr       Date:  2013-03-19       Impact factor: 5.614

8.  Dopamine Promotes Ascorbate Release from Retinal Neurons: Role of D1 Receptors and the Exchange Protein Directly Activated by cAMP type 2 (EPAC2).

Authors:  Thaísa Godinho da Encarnação; Camila Cabral Portugal; Caio Eduardo Nogueira; Felipe Nascimento Santiago; Renato Socodato; Roberto Paes-de-Carvalho
Journal:  Mol Neurobiol       Date:  2018-02-23       Impact factor: 5.590

9.  Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage.

Authors:  M V Catani; A Rossi; A Costanzo; S Sabatini; M Levrero; G Melino; L Avigliano
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

10.  Mitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifying.

Authors:  Richard Kones
Journal:  Clin Pharmacol       Date:  2010-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.